From STAT’s Matthew Herper: Pfizer said this morning that it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another medicine with ...

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

CRISPR technology uncovers new key genes and pathways linked to Parkinson’s disease, offering insights into risk and ...

A study led by Northwestern Medicine used CRISPR interference to identify Commander proteins involved in Parkinson’s disease ...

Parkinson's disease is the second most common neurodegenerative disease in the world... | Genetics And Genomics ...

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

As the demand for precision and efficiency in genetic research continues to grow, Creative Biogene's CRISPR library screening service stands out, allowing scientists to quickly identify and analyze ...

Leading artificial intelligence (AI) driven drug discovery and bioinformatics, Dr. Sita Sirisha Madugula is making ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...